This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Beijing Tuo Jie Biopharmaceutical Co. Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Fangzhou Wu: Innovator in Biopharmaceuticals
Introduction
Fangzhou Wu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative compounds.
Latest Patents
Fangzhou Wu holds a patent for a "Dual-agonist compound for both GLP-1 and GIP receptors and application thereof." This patent highlights his expertise in creating compounds that target multiple receptors, which can lead to advancements in therapeutic options.
Career Highlights
Wu is currently employed at Beijing Tuo Jie Biopharmaceutical Co. Ltd. His work at this company has positioned him as a key player in the biopharmaceutical industry, where he continues to push the boundaries of innovation.
Collaborations
Fangzhou Wu collaborates with talented individuals in his field, including Lei Wang and Xuchao Huang. These partnerships enhance the research and development efforts within his company.
Conclusion
Fangzhou Wu's contributions to biopharmaceuticals through his innovative patent and collaborative efforts underscore his role as a leading inventor in the industry. His work continues to pave the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile